Abbott Laboratories (ABT) Shares Outstanding (Diluted Average) (2009 - 2026)

Abbott Laboratories has disclosed Shares Outstanding (Diluted Average) across 18 years of filings, most recently posting $1.7 billion for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $1.7 billion, changed 0.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 billion (changed 0.01% YoY), and the FY2025 annual result was $1.7 billion, changed 0.0% from the prior year.
• Shares Outstanding (Diluted Average) came in at $1.7 billion for Q1 2026 at Abbott Laboratories, roughly flat from $1.7 billion in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $1.8 billion in Q1 2022 to a low of $1.7 billion in Q1 2026.
• The 5-year median for Shares Outstanding (Diluted Average) is $1.7 billion (2025), against an average of $1.8 billion.
• Across the five-year window, Shares Outstanding (Diluted Average) dropped 1.55% in 2022 and rose 0.09% in 2025, its largest moves.
• Abbott Laboratories' Shares Outstanding (Diluted Average) stood at $1.8 billion in 2022, then declined by 0.85% to $1.7 billion in 2023, then dropped by 0.06% to $1.7 billion in 2024, then changed by 0.0% to $1.7 billion in 2025, then retreated by 0.05% to $1.7 billion in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $1.7 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.7 billion (Q3 2025), per Business Quant data.